• FirefoxUpgrade to the new Firefox »
  •  Dow Up 2.43% Nasdaq Up 2.24%

    Gilead Sciences Inc. (GILD)

    -NasdaqGS
    105.54 3.14(3.07%) Dec 18, 4:00PM EST
    Add to Portfolio
    Prev Close:102.40
    Open:104.56
    Bid:106.09 x 100
    Ask:106.47 x 200
    1y Target Est:126.17
    Beta:1.11
    Earnings Date:Feb 2 - Feb 6 (Est.)
    Day's Range:103.66 - 105.71
    52wk Range:63.50 - 116.83
    Volume:14,285,769
    Avg Vol (3m):15,014,500
    Market Cap:159.22B
    P/E (ttm):18.80
    EPS (ttm):5.61
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    GILDUp 3.07%159.22B
    GSK104.07B
    PFE201.43B
    RHHBY250.73B

    Key Statistics

    Forward P/E (1 yr):10.46
    P/S (ttm):7.46
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :7.93
    Quarterly EPS Est (Dec-14) :2.26
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):0.54

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines for the treatment of life threatening diseases in North America, South America, Europe, and the Asia-Pacific. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback